Guselkumab does not appear to influence the IgG antibody response to SARS-CoV-2

Dermatol Ther. 2022 Feb;35(2):e15246. doi: 10.1111/dth.15246. Epub 2021 Dec 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Antibody Formation
  • COVID-19*
  • Humans
  • Immunoglobulin G
  • SARS-CoV-2*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • guselkumab